Patel Chem Specialities Reports Zero Deviation in IPO Proceeds Utilization for H1FY27
Patel Chem Specialities Ltd · Others (Uncategorized) · 05 Nov 2026, 8:05 pm
Patel Chem Specialities Reports Zero Deviation in IPO Proceeds Utilization for H1FY27 Patel Chem Specialities confirmed zero deviation in the utilization of funds raised via its ₹58.80 crore IPO allotted on 30th Jul'25, for the half-year ended 30th Sep'26. Funds allocated for issue expenses (₹7.25 crore) and general corporate purposes (₹8.40 crore) stand fully deployed, with ₹0.35 crore in surplus issue expenses transferred to CapEx. Out of the revised ₹43.49 crore CapEx allocation, ₹5.77 crore was utilized through H1FY27 (₹1.45 crore in Q1; ₹4.32 crore in Q2), leaving ₹30.47 crore unutilized and parked in bank fixed deposits.
Original exchange filing (PDF)
More announcements from Patel Chem Specialities Ltd
- In continuation of our earlier intimation dated November 2, 2026 regarding alleged non compliance with Regulation 34 of the SEBI (LODR) 2015. The Company hereby informs that BSE Limited .... · 17 Nov 2026
- Board Comments on Levy of fine by the Exchnage. · 07 Nov 2026
- Announcement under regulation 30 (LODR) · 06 Nov 2026
- Monitoring Agency Report for the Quarter Ended on 30th September, 2026. · 05 Nov 2026
- Results · 05 Nov 2026
- Unaudited Standalone Financial Results for the half year ended September 30, 2026 · 05 Nov 2026
- Imposition of Fine by BSE u/r 34 · 02 Nov 2026
- Annual Report for the F. Y 2025-26. · 31 Oct 2026
